Investigative study using blood biomarker testing for dementia in healthy subjects

Investigative study using blood biomarker testing for dementia in healthy subjects - blood biomarker testing for dementia in healthy subjects

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054688

Enrollment

100

Registered

2024-06-18

Start date

2024-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adults between the ages of 40 and 85 at the time consent is obtained.

Exclusion criteria

Exclusion criteria: (i) Has participated or is currently participating in an Alzheimer's disease drug trial within the past 12 months and has received a therapeutic intervention. (ii) Has any of the following: mild cognitive impairment, Alzheimer's disease, Parkinson's disease, cerebrovascular dementia, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or head injury with neurological dropout symptoms or abnormal brain structure (iii) History of depression, bipolar disorder, or bipolar disorder. (iii) History of depression, bipolar disorder, schizophrenia, alcohol or drug abuse or dependence.

Design outcomes

Primary

Measure	Time frame
Background information and neuropsychological assessment of the study subjects, healthy volunteers, will be evaluated in relation to blood biomarker measurements.	—

Countries

Japan

Contacts

Public ContactKenji Tagai

Institute of Quantum Science and Medical Science, National Institute of Quantum Science and Technolo Center for Functional Brain Imaging

tagai.kenji@qst.go.jp043-206-3251

Outcome results